Rockwell Medical

Founded in 1996 and based in Wixom, Michigan, Rockwell Medical is a pharmaceutical company dedicated to the development and commercialization of treatments for end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company's core mission is to improve the quality of life for patients suffering from these severe kidney conditions through innovative therapies. Rockwell Medical offers a range of products designed to address the unique needs of renal patients, focusing primarily on iron maintenance therapy and hemodialysis concentrates.

Rockwell Medical has garnered attention from notable investors and stakeholders in the healthcare sector. Over the years, the company has achieved significant milestones, including FDA approvals for its key products. These accomplishments have positioned Rockwell Medical as a leader in the niche market of renal disease treatment. The company's impact is reflected in its commitment to advancing patient care and its ongoing efforts to bring new, effective therapies to market.